Targeting Cdc20 as a novel cancer therapeutic strategy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting Cdc20 as a novel cancer therapeutic strategy

Published:2015-07 Issue: Volume:151 Page:141-151
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Wang Lixia,Zhang Jinfang,Wan Lixin,Zhou Xiuxia,Wang Zhiwei,Wei Wenyi

Funder

NIH

NSFC

Jiangsu higher education institutions

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference155 articles.

1. The proteasome: a suitable antineoplastic target;Adams;Nat Rev Cancer,2004

2. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim;Akiyama;EMBO J,2003

3. Bim-targeted cancer therapy: a link between drug action and underlying molecular changes;Akiyama;Mol Cancer Ther,2009

4. Bim: guardian of tissue homeostasis and critical regulator of the immune system, tumorigenesis and bone biology;Akiyama;Arch Immunol Ther Exp (Warsz),2011

5. New orally active proteasome inhibitors in multiple myeloma;Allegra;Leuk Res,2014

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early-stage biomarkers identification by integrated genomic analysis in hepatocellular carcinoma;Medicine in Omics;2024-12

2. Identification of an oncogenic role of centromere protein M in non-small cell lung cancer via CDC20/MYBL2/Wnt signals;2024-09-02

3. Six drivers of aging identified among genes differentially expressed with age;2024-08-06

4. Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast Cancer;Cancers;2024-07-15

5. RUNX1 regulates MCM2/CDC20 to promote COAD progression modified by deubiquitination of USP31;Scientific Reports;2024-06-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3